Tenovin-6, an SIRT1 inhibitor, in combination with metformin, an activator of AMP-activated protein kinase (AMPK), inhibits growth in non-small cell lung cancer (NSCLC) cells [15]. This evidence concerns the gene SIRT1 and non-small cell lung carcinoma.